Tacrolimus (FK506) Antikörper
Kurzübersicht für Tacrolimus (FK506) Antikörper (ABIN1722861)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Reacts with conjugated and non-conjugated FK-506 (Kd=10E-9M)
-
Aufreinigung
- Purified
-
Immunogen
- FK-506 conjugated to bovine serum albumin.
-
Isotyp
- IgM
-
-
-
-
Applikationshinweise
- Working dilution: Optimal dilution should be determined by the end user.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Dilute in PBS or medium which is identical to that used in the assay system.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Tacrolimus (FK506)
-
Andere Bezeichnung
- FK-506
-
Substanzklasse
- Chemical
-
Hintergrund
-
FK-506 is a novel macrolide with similar, but more potent, immunosuppressant activity than cyclosporine. FK-506 is used for primary or rescue immunosuppression in patients after solid organ transplantation. Clinically relevant side effects of FK-506 administration are nephrotoxicity, neurotoxicity, diabetes mellitus, and hypertension. Most of these side effects are related to blood levels of FK-506 rather than dosage. Therefore, therapeutic drug monitoring of FK-506 is a prerequisite for therapy. The whole blood target level range aimed for in clinical practice is 3.0-20.0 ng/mL and depends on the patient's liver function, the nature of organ transplantation, and the time after transplantation.
Tacrolimus Fujimycin CAS : 109581-93-3 C44H69NO12 . H2O
Target
-